Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-377.29M | +3.6% |
| 2024 | $-391.53M | -31.8% |
| 2023 | $-297.06M | +5.5% |
| 2022 | $-314.36M | +23.9% |
| 2021 | $-413.06M | -35.5% |
| 2020 | $-304.87M | +20.4% |
| 2019 | $-382.79M | -22.9% |
| 2018 | $-311.41M | -7.4% |
| 2017 | $-289.86M | -1111.8% |
| 2016 | $28.65M | - |